Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal Acetate in Early Pregnancy Loss
NCT05216952Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- May 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ulipristal in early pregnancy loss (EPL), sponsored by University of North Carolina at Chapel Hill. Started May 2022; status: completed.
02
Drugs
ulipristal
03
Conditions
early pregnancy loss (EPL)
Beyond the preview
Go deeper on NCT05216952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05216952.